Genital Herpes Market, By Drug (Acyclovir, Valacyclovir, Famciclovir and Others), By Route of Administration (Oral, Injection and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Growing rates of STDs, rising usage of herpes treatment, rising awareness of STDs, rising use of targeted herpes treatment procedures, rising rates of hospital-acquired infections, and rising demand for efficacious therapeutic treatment are the main factors propelling the market's expansion. In addition, the industry is expanding due to increased government funding for the development of novel treatments for genital herpes, a rise in the demand for minimally invasive procedures, a rise in the emergence of species resistant to antivirals, research and development efforts to enhance the quality of drug treatment methods, and partnerships and cooperation among major industry participants.